Efficacy of vemurafenib, a selective BRAFV600E inhibitor, in combination with a MEK inhibitor in BRAFV600E colorectal cancer models.

被引：1
|
作者：
Higgins, Brian
Kolinsky, Kenneth Daniel
Yang, Hong
Kim, Min Jung
Li, Jia Kui
Go, Zenaida
Packman, Kathryn
Bollag, Gideon
Su, Fei
机构：
[1] Hoffmann Roche Inc, Pharma Res & Early Dev, Nutley, NJ USA
[2] Plexxikon Inc, Berkeley, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.488
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
488
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical efficacy of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patients
    Corcoran, R.
    Giannakis, M.
    Allen, J.
    Chen, J.
    Pelka, K.
    Chao, S.
    Meyerhardt, J.
    Enzinger, A.
    Enzinger, P.
    McCleary, N.
    Yugelun, M.
    Abrams, T.
    Kanter, K.
    Van Seventer, E.
    Bradford, W.
    Fetter, I.
    Siravegna, G.
    Tian, J.
    Clark, J.
    Ryan, D.
    Hacohen, N.
    Parikh, A.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S226 - S227
  • [42] Vemurafenib enhances MHC induction in BRAFV600E homozygous melanoma cells
    Sapkota, Bishu
    Hill, Charles E.
    Pollack, Brian P.
    [J]. ONCOIMMUNOLOGY, 2013, 2 (01):
  • [43] The Evolutionary Landscape of Treatment for BRAFV600E Mutant Metastatic Colorectal Cancer
    Mauri, Gianluca
    Bonazzina, Erica
    Amatu, Alessio
    Tosi, Federica
    Bencardino, Katia
    Gori, Viviana
    Massihnia, Daniela
    Cipani, Tiziana
    Spina, Francesco
    Ghezzi, Silvia
    Siena, Salvatore
    Sartore-Bianchi, Andrea
    [J]. CANCERS, 2021, 13 (01) : 1 - 15
  • [44] SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells
    Klotz-Noack, Kathleen
    Klinger, Bertram
    Rivera, Maria
    Bublitz, Natalie
    Uhlitz, Florian
    Riemer, Pamela
    Luethen, Mareen
    Sell, Thomas
    Kasack, Katharina
    Gastl, Bastian
    Ispasanie, Sylvia S. S.
    Simon, Tincy
    Janssen, Nicole
    Schwab, Matthias
    Zuber, Johannes
    Horst, David
    Bluethgen, Nils
    Schaefer, Reinhold
    Morkel, Markus
    Sers, Christine
    [J]. CELL REPORTS, 2020, 32 (12):
  • [45] SURVIVAL ADVANTAGE WITH EVEROLIMUS (RAD001) COMBINED WITH A SELECTIVE BRAFV600E INHIBITOR IN A XENOGRAFT MODEL OF BRAFV600E-MUTANT PEDIATRIC GLIOMA
    Dasgupta, Tina
    Olow, Aleksandra
    Yang, Xiaodong
    Hashizume, Rintaro
    Mueller, Sabine
    Nicolaides, Theodore
    Kolkowitz, Ilan
    Weiss, William
    Prados, Michael
    Gupta, Nalin
    James, C. David
    Haas-Kogan, Daphne
    [J]. NEURO-ONCOLOGY, 2013, 15 : 43 - 43
  • [46] Clinical significance of the BRAFV600E mutation in Asian patients with colorectal cancer
    Hou-Hsuan Cheng
    Jen-Kou Lin
    Wei-Shone Chen
    Jeng-Kai Jiang
    Shung-Haur Yang
    Shih-Ching Chang
    [J]. International Journal of Colorectal Disease, 2018, 33 : 1173 - 1181
  • [47] Clinical significance of the BRAFV600E mutation in Asian patients with colorectal cancer
    Cheng, Hou-Hsuan
    Lin, Jen-Kou
    Chen, Wei-Shone
    Jiang, Jeng-Kai
    Yang, Shung-Haur
    Chang, Shih-Ching
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2018, 33 (09) : 1173 - 1181
  • [48] Survival Advantage With Radiation Combined With a Selective BRAFV600E Inhibitor in an Orthotopic, Intracranial Model of BRAFV600E-mutated High-grade Gliomas
    Dasgupta, T.
    Yang, X.
    Hashizume, R.
    Olow, A.
    Kolkowitz, I.
    Weiss, W.
    Mueller, S.
    Nicolaides, T.
    James, C. D.
    Haas-Kogan, D. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S125 - S125
  • [49] BRAFV600E Overrides NOTCH Signaling in Thyroid Cancer
    Traversi, Florian
    Stooss, Amandine
    Dettmer, Matthias S.
    Charles, Roch-Philippe
    [J]. THYROID, 2021, 31 (05) : 787 - 799
  • [50] A biomarker of response to therapy in metastatic BRAFV600E colorectal cancers
    [J]. Nature Medicine, 2022, 28 : 2015 - 2016
12345